CAR T-Cells for the Treatment of Hematological Malignancies and Solid Tumours

Explore the cutting-edge field of CAR T-cell therapy through this comprehensive webinar featuring expert presentations on treating both blood cancers and solid tumors. Learn from leading researchers Sonia Guedan from IDIBAPS Spain, David Stahl from EKF Germany, and Tobias Weiss from the University of Zurich Switzerland as they share their insights on this revolutionary immunotherapy approach. Discover the latest developments in chimeric antigen receptor T-cell technology, understand the mechanisms behind CAR T-cell function, and examine current applications in hematological malignancies while exploring emerging strategies for solid tumor treatment. Gain valuable knowledge about the challenges and opportunities in this rapidly evolving therapeutic field through expert analysis and research findings presented in this collaborative effort between the European Association for Cancer Research, Young European Hematology Association, and Young European Federation of Immunological Societies.